Clinical outcome of osteosarcoma and its correlation with programmed death-ligand 1 and T cell activation markers

Clinical outcome of osteosarcoma and its correlation with programmed death-ligand 1 and T cell activation markers

Kazushige Yoshida,1 Masanori Okamoto,1 Jun Sasaki,1 Chika Kuroda,2 Haruka Ishida,2 Katsuya Ueda,2 Satomi Okano,2 Hirokazu Ideta,1 Takayuki Kamanaka,1 Atsushi Sobajima,1 Takashi Takizawa,1 Munehisa Kito,1 Kaoru Aoki,3 Takeshi Uemura,2 Hisao Haniu,2 Hiroyuki Kato,1 Naoto Saito2 1Department of Orthopa...

Full description

Bibliographic Details
Main Authors: Yoshida K, Okamoto M, Sasaki J, Kuroda C, Ishida H, Ueda K, Okano S, Ideta H, Kamanaka T, Sobajima A, Takizawa T, Kito M, Aoki K, Uemura T, Haniu H, Kato H, Saito N
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:OncoTargets and Therapy
Subjects:
anti-PD-1 antibody
perforin
granzyme B
IFNγ
osteosarcoma
clinical outcome
Online Access:https://www.dovepress.com/clinical-outcome-of-osteosarcoma-and-its-correlation-with-programmed-d-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/clinical-outcome-of-osteosarcoma-and-its-correlation-with-programmed-d-peer-reviewed-article-OTT

Similar Items